Discover B2B companies, suppliers, and manufacturers related to this keyword category
New Paradigm in Cancer Drug Discovery: Dissociating HK2/VDAC and pro-immune Tumor microenvironment . Clinical Stage.
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation
We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward.
Decoding Fibroblast Biology to Create Superior Therapeutics
Providing a best-in-class digital cytometry that simplifies cellular profiling and accelerates biomarker discovery
Research on : Molecular Vulnerabilities of Tumor Escape in mature B-cell Malignancies